在危急病患者中通过连续输液给药的万科米辛的人口药理动力学
Haifa Ben Romdhane1, Jean Baptiste Woillard2, Najah Ben Fadhel1
1Department of Pharmacology, EPS Fattouma Bourguiba, Faculty of Medicine, University of Monastir, Monastir, Tunisia.
这项研究开发了一种种群体药理动力学 (Pop Pk) 模型,用于危重病患者的万科米辛持续输液. 该模型展示了功能如何影响菌素清除,有助于优化剂量以改善患者的治疗结果.
科学领域:
- 药理动力学和药理动力学
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 持续输液 (CI) 范科米辛剂量建议用于生理变化的重症患者.
- 种群药动力学 (Pop Pk) 模型对于优化这种种群中的万科米辛治疗至关重要.
研究的目的:
- 开发和验证通过CI给药的万科米辛的Pop Pk模型.
- 评估功能对危重病患者万科米辛药理学的影响.
主要方法:
- 使用了一个非参数的Pop Pk方法 (Pmetrics).
- 分析了包括年龄和肌素清除率 (Cr-Cl) 在内的共变量,以确定它们对药理动力学参数的影响.
- 用内部和外部数据集验证模型性能.
主要成果:
- 一个单间模型有效预测了万科米辛度.
- 年龄和Cr-Cl分别显著影响了米素的分发量 (Vd) 和排泄率 (Ke).
- 香草素清除率 (CLv) 与功能障碍的严重程度呈负相关性,内部验证的R平方值为0.86.
结论:
- 建立了一种经过验证的Pop Pk模型,用于在重症患者中持续输注万科米辛.
- 肌素清除和功能衰竭阶段显著影响万科米辛清除.
- 基于该模型的个性化剂量建议可以优化万科米辛的疗效和安全性.
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
06:18A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
相关概念视频
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
Compartment Models: Single-Compartment Model
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
